HTATIP2 and cancer: This suggests that high expression of TIP30 might be associated with a prolonged overall survival time of cancer patients (random effect model HR = 0.53, 95% CI: 0.41–0.69), but significant heterogeneity was detected among studies (Chi2 = 30.69, df = 10, p = 0.0007, I2 = 67%) (Fig 2).